ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

A Prognostic Model Based on Residual Cancer Burden and Tumor-Infiltrating Lymphocytes on Residual Disease after Neoadjuvant Therapy in HER2+ Breast Cancer.

Federica Miglietta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.